Effect of Ocimum basilicum on sleep quality in menopausal women

The effect of oral capsule of Ocimum basilicum leaf extract on sleep quality in menopausal women

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200104046001N1

Enrollment

Registered

2020-01-10

Start date

2020-02-09

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleep disorder. Sleep disorders

Interventions

Intervention 1: Intervention group: Intervention group: Oral Extract of Ocimum Basilicum Leaf Extract Made in the Pharmacology Department of Mashhad University of Medical Sciences, each capsule contai

Eligibility

Sex/Gender

Female

Age

40 Years to 65 Years

Inclusion criteria

Inclusion criteria: At least literacy Being a postmenopausal patient(Have at least 12 months spontaneous abstinence, with no association with pregnancy, lactation, or other medical, pharmaceutical, or serum FSH levels> 40IU / L.) Having a sleep quality score above 5 Age 40 to 65 years No history of sleep disorder requiring medical intervention (according to the person) Lack of allergy to Ocimum basilicum

Exclusion criteria

Exclusion criteria: Smoking and alcohol Hormone therapy in the past 6 months Having severe depression, stress, or severe anxiety(A score of less than 19 under the stress scale, a score of less than 10 under the anxiety scale, or a score of less than 14 under the DASS-21 Depression Scale) Medical illness(Such as, asthma, restless leg syndrome, kidney failure, liver disease,, chronic illness, seizure, Parkinson's disease, epilepsy, arthritis) Mental illness(Delirium, Schizophrenia, Alzheimer's) Infectious and feverish diseases(Respiratory tract infection, urinary and hepatitis, influenza, arthritis) Use herbal sleep medicines that affect sleep(Lavender, Spring Orange, Basil Lemon, herbal tea of Ocimum basilicum) Concomitant use of sleep-inducing chemical drugs(Clonidine, antidepressants, tamoxifen, raloxifene, anticonvulsants such as gabapentin, sedative) Use of anti-coagulants, anxiolytic drugs Having a night shift

Design outcomes

Primary

Measure	Time frame
Sleep quality. Timepoint: Before the study and immediately after the intervention. Method of measurement: Pittsburgh Sleep Quality Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contact????? ?????

Mashhad University of Medical Sciences

hoseinih971@mums.ac.ir+98 51 3859 1511

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 10, 2026